The Role of Cannabinoids in Advancing Cancer Treatment: Insights from Evidence-Based Medicine

Abstract Purpose of Review This document critically examines the role of cannabinoids in cancer care during an era marked by rapid advancements in oncology and

March 22, 2026

The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology

Abstract Cannabinoids are a group of chemicals that bind to receptors in the human body and, in turn, modulate the endocannabinoid system (ECS). They can

April 1, 2024

The Role of Cannabidiol in Neurological Disorders

Abstract Cannabis has been used for both recreational and medicinal purposes for more than 4 millennia. Cannabis has been studied in various medical disorders including

May 30, 2024

The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence

Please use this link to access this publication. Abstract Purpose of Review Given the growing challenges in chronic pain management coupled with the ongoing consequences

July 1, 2024

The Role of Atypical Cannabinoid Ligands O-1602 and O-1918 on Skeletal Muscle Homeostasis with a Focus on Obesity

Abstract O-1602 and O-1918 are atypical cannabinoid ligands for GPR55 and GPR18, which may be novel pharmaceuticals for the treatment of obesity by targeting energy

September 25, 2025

The Risks and Benefits of Cannabis in the Dermatology Clinic

Abstract Cannabis (Cannabis sativa/indica), also known as marijuana, has been used for medicinal and recreational purposes for millennia. There has been a recent trend to

October 30, 2024

The resurgence of synthetic cannabinoid receptor agonists as adulterants in the Era of Cannabis legalization: Lessons from prior epidemics and clinical implications

Please use this link to access this publication. Abstract Momentum towards legalization of medical and recreational cannabis drives a convergence between natural cannabinoids and their synthetic counterparts,

January 31, 2026

The relationship of medical and recreational cannabis laws with opioid misuse and opioid use disorder in the USA: Does it depend on prior history of cannabis use?

Please use this link to access this publication. Abstract Background Wider availability of cannabis through medical and recreational legalization (MCL alone and RCL+MCL) has been

March 3, 2025

The Relationship of glutamate signaling to cannabis use and schizophrenia

Please use this link to access this publication. Abstract Purpose of review This review examines the literature associating cannabis with schizophrenia, glutamate dysregulation in schizophrenia,

November 22, 2025

The Relationship Between Plasma Tetrahydrocannabinol Levels and Intraocular Pressure in Healthy Adult Subjects

February 15, 2024